dawn heleos ii multi angle light scattering detector Search Results


dawn heleos mals detector  (Waters Corporation)
99
Waters Corporation dawn heleos mals detector
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Dawn Heleos Mals Detector, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/DAWN/pmc04611662-293-40-56
Average 99 stars, based on 1 article reviews
dawn heleos mals detector - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
dawn heleos multi angle laser light  (Waters Corporation)
99
Waters Corporation dawn heleos multi angle laser light
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Dawn Heleos Multi Angle Laser Light, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/Optilab/pm35736562__ja2c04032_si_001-62-34-48
Average 99 stars, based on 1 article reviews
dawn heleos multi angle laser light - by Bioz Stars, 2026-10
99/100 stars
  Buy from Supplier
amplatzer cribriform multi fenestrated septal occluder device  (Abbott Laboratories)
86
Abbott Laboratories amplatzer cribriform multi fenestrated septal occluder device
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Amplatzer Cribriform Multi Fenestrated Septal Occluder Device, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/amplatzer+occluder+septal/pm41043908-56-2-8
Average 86 stars, based on 1 article reviews
amplatzer cribriform multi fenestrated septal occluder device - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier
occlutech® accell® flex ii septal occluder  (Occlutech GmbH)
90
Occlutech GmbH occlutech® accell® flex ii septal occluder
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Occlutech® Accell® Flex Ii Septal Occluder, supplied by Occlutech GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/occlutech+septal+occluder/10__1017_slash_s104795111700110x-17776-13-12
Average 90 stars, based on 1 article reviews
occlutech® accell® flex ii septal occluder - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier
dawn heleos ii multi angle light scattering detector  (Waters Corporation)
95
Waters Corporation dawn heleos ii multi angle light scattering detector
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Dawn Heleos Ii Multi Angle Light Scattering Detector, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/WyattQELS/pmc10708492-123-36-52
Average 95 stars, based on 1 article reviews
dawn heleos ii multi angle light scattering detector - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier
multi angle light scattering detector  (Waters Corporation)
97
Waters Corporation multi angle light scattering detector
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Multi Angle Light Scattering Detector, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/miniDAWN/10__1039_slash_d4py00505h-75-36-40
Average 97 stars, based on 1 article reviews
multi angle light scattering detector - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier
multi angle light scattering system  (Waters Corporation)
96
Waters Corporation multi angle light scattering system
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Multi Angle Light Scattering System, supplied by Waters Corporation, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/Eclipse/pm34559985-420-24-36
Average 96 stars, based on 1 article reviews
multi angle light scattering system - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier
gpc-mals  (Shoko Co Ltd)
90
Shoko Co Ltd gpc-mals
(A) <t>SEC-MALS:</t> Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn <t>Heleos</t> MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.
Gpc Mals, supplied by Shoko Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/dawn+heleos+ii+multi+angle+light+scattering+detector/gpc+mals/10__1007_slash_s13233___012___0057___7-47-24-25
Average 90 stars, based on 1 article reviews
gpc-mals - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


(A) SEC-MALS: Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn Heleos MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Article Title: Local and global structural drivers for the photoactivation of the orange carotenoid protein

doi: 10.1073/pnas.1512240112

Figure Lengend Snippet: (A) SEC-MALS: Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCPO samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn Heleos MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.). The data shown are directly from the Astra software. The scattering signal indicates no change in peak characteristics of the major component, OCP-monomer (peak “1”) upon X-ray irradiation. The dRI signal indicates presence of buffer components (peak “2” in all of the samples) and methionine amide (peak “3” in the irradiated samples). (B) Representative XF-MS dose–response plots: peptide modification as a function of X-ray irradiation dose for residue and residues clusters of OCPO, (black squares) and illuminated OCPR, (red circles). Error bars represent the SE from three independent measurements. The solid lines represent single-exponential fits to the dose-dependent data. The ratio of the modification rates (R) indicates the change in relative accessibilities, which are shown in Table S6.

Article Snippet: Open in a separate window Fig. S5. ( A ) SEC-MALS: Chromatogram of MALS (red) and differential refractive index (dRI) (blue) from SEC of “zero” and X-ray irradiated OCP O samples using Ethan LC (GE Healthcare Life Science) coupled to Dawn Heleos MALS detector with an embedded dynamics light scattering detector and Optilab rEX dRI detector (Wyatt Technology Corp.).

Techniques: Refractive Index, Irradiation, Multi-Angle Light Scattering, Software, Modification, Residue